Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Durability data demonstrates long-term performance of Sorin pericardial heart valve

Sorin : 17 September, 2008  (Company News)
A report detailing 21-year durability data of Sorin’s Mitroflow Aortic Pericardial Heart Valve has been published in the September issue of the Journal Of Thoracic And Cardiovascular Surgery.
The Mitroflow Aortic Pericardial Heart Valve, a biological heart valve, was introduced in Europe in 1982. In over 20 years of clinical use it has demonstrated superior haemodynamic performance and proven long-term durability in a design recognised by surgeons worldwide for its ease of Implant in even the most challenging anatomies.

Biological valves are increasingly used to replace diseased native valves. They are designed to improve the patient's quality of life by obviating the need for lifelong anticoagulation therapy.

“To date, the Mitroflow pericardial bioprosthesis has demonstrated excellent durability at 21 years. I am particularly happy to be able to provide long-term durability to my patients”, said prof Charles Yankah, associate professor of surgery, Charite Medical University, Berlin, Germany and Consultant CardioThoracic and Vascular Surgeon, Berlin Herzzentrum, Berlin, Germany.

“The 21 year data represents the longest patient follow up ever published in the history of pericardial valves and represents a new benchmark for all pericardial valves today,” said Stefano Di Lullo, president Heart Valves Business Unit of Sorin Group. “We are delighted that this peer-reviewed scientific journal confirms the proven long-term durability of the Mitroflow valve in addition to its already recognized best-in-class haemodynamic performance”.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo